AA

Ajit Abhimanyu Sangai

Active Director Director DIN 08231029
DIN 08231029 First appointment Sep 2018 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Ajit Abhimanyu Sangai

Data last updated:

Ajit Abhimanyu Sangai is a Director at Medimart Generic Medicines India Private Limited (since 2018). The company operates in Food And Beverages.

DIN 08231029
Primary Designation Director
Industry Food And Beverages
First Appointment 20 Sep 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Sep 20182018Active

Board colleagues of Ajit Abhimanyu Sangai

Directorship timeline

Open interactive timeline →
Medimart Generic Medicines India Private Limited
Premium access

Shareholding and investment profile for Ajit Abhimanyu Sangai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajit Abhimanyu Sangai

Ajit Abhimanyu Sangai currently holds 1 directorship: Medimart Generic Medicines India Private Limited (Director, since 20 Sep 2018).

Ajit Abhimanyu Sangai was first appointed on 20 Sep 2018 as Director at Medimart Generic Medicines India Private Limited.

The current boards of Ajit Abhimanyu Sangai's companies include Nandkumar Lahu Kore (Medimart Generic Medicines India Private Limited), Rajkumar Lahu Kore (Medimart Generic Medicines India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available